Back

Cardiovascular and non-cardiovascular adverse events in patients with hematologic malignacies treated with BTK inhibitors: a real-world analysis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Challenges when caring for cancer patients with heart disease Cardio-Oncology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Rafael Belo Nunes

Hospital Alemao Oswaldo Cruz, Sao Paulo (Brazil)

3 More presentations in this session

Presentation thumbnail
Early rhythm control of atrial fibrillation in cancer survivors: a nationwide population-based cohort study
Doctor S. Han (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
The prognostic value of advanced lung cancer inflammation index in cancer survivors complicated with cardiovascular disease
Doctor Y. Zhang (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Machine learning and traditional analysis of the interaction between cardiovascular diseases and hematological malignancies
Doctor T. Itkin (Tel Aviv, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Challenges when caring for cancer patients with heart disease
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources